Véronique Lecault
Founder at ABCELLERA BIOLOGICS INC.
Net worth: 28 M $ as of 2024-06-29
Véronique Lecault active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ABCELLERA BIOLOGICS INC. | Director/Board Member | 2012-11-07 | - |
| Chief Operating Officer | 2012-11-07 | - | |
| Founder | 2012-11-07 | - | |
Lineage Biosciences, Inc.
 Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Lineage Biosciences, Inc. engages in biotechnology services. The company was founded on May 30, 2014 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 2017-12-31 | - |
| AbCellera Australia Pty Ltd. | Director/Board Member | 2019-08-31 | - |
Trianni, Inc.
 Trianni, Inc. BiotechnologyHealth Technology TRIANNI, Inc. operates as a biotech company. It specializes in antibody discovery technology using transgenic mice. Its Trianni Mouse platform enables the generation of fully-human monoclonal antibodies. The company was founded in 2010 and is headquartered in San Francisco, CA. | Director/Board Member | 2020-10-31 | - |
Career history of Véronique Lecault
Training of Véronique Lecault
| University of British Columbia | Doctorate Degree |
| University of Ottawa | Undergraduate Degree |
Statistics
International
| Canada | 5 |
| Australia | 2 |
| United States | 2 |
Operational
| Director/Board Member | 3 |
| Chief Operating Officer | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ABCELLERA BIOLOGICS INC. | Health Technology |
| Private companies | 3 |
|---|---|
Lineage Biosciences, Inc.
Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Lineage Biosciences, Inc. engages in biotechnology services. The company was founded on May 30, 2014 and is headquartered in Vancouver, Canada. | Health Services |
| AbCellera Australia Pty Ltd. | |
Trianni, Inc.
Trianni, Inc. BiotechnologyHealth Technology TRIANNI, Inc. operates as a biotech company. It specializes in antibody discovery technology using transgenic mice. Its Trianni Mouse platform enables the generation of fully-human monoclonal antibodies. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Véronique Lecault
- Experience
